Novel, cross-restricted, conserved, and immunodominant Cytotoxic T Lymphocyte epitopes in slow progressors in HIV Type 1 infection
Goulder, P.J.R., Bunce, M., Krausa, P., McIntyre, K., Crowley, S., Morgan, B., Edwards, A., Giangrande, P., Phillips, R.E. and McMichael, A.J. (1996) Novel, cross-restricted, conserved, and immunodominant Cytotoxic T Lymphocyte epitopes in slow progressors in HIV Type 1 infection. AIDS Research and Human Retroviruses, 12 (18). pp. 1691-1698.
|PDF - Published Version |
Download (1064kB) | Preview
*Subscription may be required
HIV-specific cytotoxic T lymphocytes (CTLs) play an important role in the immune response to HIV infection. Long-term nonprogressors (LTNPs) or slow progressors (SPs) in HIV infection may make qualitatively different CTL responses compared to those generated by seropositive individuals who progress to disease at a faster rate. The class I molecule HLA-B*57 has been identified as one restriction element overrepresented in SP groups studied, and, together with the closely related molecule HLA-B*58, occurs commonly in ethnic groups where HTV is most prevalent. In this study, we have identified five new HLA-B*57-restricted CTL epitopes recognized by SP donors, one of which is also HLA-B*5801 restricted. These HLA-B*57-restricted responses represent the dominant HIV-specific CTL response in each of the SP donors tested. These and other such epitopes may be an important component in future vaccine design.
|Publication Type:||Journal Article|
|Publisher:||Mary Ann Liebert|
|Copyright:||1996 Goulder et al.|
|Item Control Page|